The decision could be made sooner than expected. The European Medicines Agency (EMA) announced on Monday that it could comment on the Moderna vaccine during the day, instead of Wednesday as initially planned. “Today there is a meeting of the EMA’s Committee for Medicinal Products for Human Use (CHMP) to discuss the Moderna vaccine,” the European regulator said in a statement.
A new press release could be published during the day “in case the CHMP succeeds in a decision during today’s meeting ”. Otherwise, the Committee would meet again on Wednesday. The EMA has authorized the 20 December vaccine against Covid – 19 Pfizer / BioNTech, for which the European Commission immediately gave the green light, and was due to vote on Moderna’s on January 6.
Two doses
The Moderna vaccine is taken in two doses, a few weeks apart, such as Pfizer / BioNTech vaccine . But Moderna’s formula can be kept at – 19 ° C, and not – 21 ° C as for the remedy from Pfizer, which forced the group to develop specific containers for transport.
The United States Drugs Agency (FDA) announced on 18 December that she had granted this American laboratory an authorization emergency, a week after doing the same with Pfizer and BioNTech. The EMA headquarters moved from London to Amsterdam as a consequence of Brexit. 20210104